United Services Automobile Association Lowers stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : United Services Automobile Association reduced its stake in Thermo Fisher Scientific by 0.21% during the Q4 period. The investment management company now holds a total of 482,100 shares of Thermo Fisher Scientific which is valued at $67.5 Million after selling 1,025 shares in Thermo Fisher Scientific according to the most recent disclosure to the SEC.Thermo Fisher Scientific makes up approximately 0.24% of United Services Automobile Association’s portfolio.

Other Hedge Funds, Including , Glenview Capital Management reduced its stake in TMO by selling 2,577,873 shares or 30.29% during the fourth quarter. The Hedge Fund company now holds 5,933,331 shares of TMO which is valued at $830.7 Million. Thermo Fisher Scientific makes up approx 4.78% of Glenview Capital Management’s portfolio.Parsons Capital Management Incri reduced its stake in TMO by selling 34 shares or 0.09% during the fourth quarter. The Hedge Fund company now holds 38,797 shares of TMO which is valued at $5.4 Million. Thermo Fisher Scientific makes up approx 0.75% of Parsons Capital Management Incri’s portfolio. Madden Advisory Services sold out all of its stake in TMO during the fourth quarter. The investment firm sold 198 shares of TMO which is valued $27,720.Boston Financial Mangement Inc reduced its stake in TMO by selling 4,542 shares or 16.25% during the fourth quarter. The Hedge Fund company now holds 23,406 shares of TMO which is valued at $3.3 Million. Thermo Fisher Scientific makes up approx 0.47% of Boston Financial Mangement Inc’s portfolio.Sol Capital Co reduced its stake in TMO by selling 100 shares or 2.99% during the fourth quarter. The Hedge Fund company now holds 3,250 shares of TMO which is valued at $455,715. Thermo Fisher Scientific makes up approx 0.16% of Sol Capital Co’s portfolio.

On the company’s financial health, Thermo Fisher Scientific reported $2.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 28, 2016. Analyst had a consensus of $2.11. The company had revenue of $4652.50 million for the quarter, compared to analysts expectations of $4551.79 million. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.99 EPS.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .Company shares were Reiterated by Topeka Capital Markets on Mar 2, 2016 to “Buy”, Firm has raised the Price Target to $ 155 from a previous price target of $145 .Company shares were Reiterated by Stifel on Jan 11, 2016 to “Buy”, Firm has raised the Price Target to $ 158 from a previous price target of $150 .

Thermo Fisher Scientific opened for trading at $142.18 and hit $144.93 on the upside on Monday, eventually ending the session at $144.05, with a gain of 0.97% or 1.38 points. The heightened volatility saw the trading volume jump to 18,51,979 shares. Company has a market cap of $57,082 M.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

NO COMMENTS

LEAVE A REPLY